Five‐Grass‐Pollen Sublingual Immunotherapy Drops Are Efficacious and Well Tolerated in Adults: The <scp>RHAPSODY</scp> Phase <scp>III</scp> Trial

20250 citationsJournal Articlehybrid Open Access

Authors

Ruta Gronskyte Juhl · ALK-Abelló (Denmark)

Abstract

RHAPSODY was the first well-powered clinical trial to show the positive risk-benefit ratio of 5-grass-pollen SLIT drops in adult participants with moderate-to-severe grass-pollen-induced ARC.

Topics & Keywords

Allergic Rhinitis and Sensitization Sinusitis and nasal conditions Ocular Surface and Contact Lens

Publication Details

Published in: Allergy

DOI: 10.1111/all.70191

Field-Weighted Citation Impact: 0.00

Command Palette

Five‐Grass‐Pollen Sublingual Immunotherapy Drops Are Efficacious and Well Tolerated in Adults: The <scp>RHAPSODY</scp> Phase <scp>III</scp> Trial

Authors

Abstract

Topics & Keywords

Publication Details